Application 209701
- Type
- ANDA
- Sponsor
- XIROMED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | OINTMENT;TOPICAL | 0.05% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209701-001 | CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | 0.05% | OINTMENT / TOPICAL | AB | 2018-04-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209701-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209701-001 | CLOBETASOL PROPIONATE | 0.05% | OINTMENT / TOPICAL | AB | 2018-04-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209701-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clobetasol Propionate | CLOBETASOL PROPIONATE | AvKARE | a862de41-1500-9136-e053-2a95a90a6080 | 2023-07-03 | Adverse reactions | 209701 ANDA209701 42291-077 |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | A-S Medication Solutions | f8e06ea9-bd18-48db-9f53-8e75734c8f01 | 2023-03-27 | Adverse reactions | 209701 ANDA209701 |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Xiromed, LLC | 56e6d233-d9ee-f022-3be7-d100799a561e | 2020-11-06 | Adverse reactions | 209701 ANDA209701 70700-106 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42291-077 | Clobetasol Propionate | clobetasol propionate | AvKARE | ANDA | Current |
| 42291-077 | Clobetasol Propionate | clobetasol propionate | AvKARE | ANDA | Current |
| 70700-106 | Clobetasol Propionate | clobetasol propionate | Xiromed, LLC | ANDA | Current |
| 70700-106 | Clobetasol Propionate | clobetasol propionate | Xiromed, LLC | ANDA | Current |
| 70700-106 | Clobetasol Propionate | clobetasol propionate | Xiromed, LLC | ANDA | Current |
| 70700-106 | Clobetasol Propionate | clobetasol propionate | Xiromed, LLC | ANDA | Current |
| 70700-106 | Clobetasol Propionate | clobetasol propionate | Xiromed, LLC | ANDA | Current |